Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2015. Start Trial.
Date Value
October 23, 2026 9.732
October 22, 2026 9.717
October 21, 2026 9.553
October 20, 2026 9.370
October 19, 2026 9.195
October 16, 2026 9.007
October 15, 2026 9.062
October 14, 2026 9.077
October 13, 2026 8.926
October 12, 2026 9.077
October 09, 2026 9.166
October 08, 2026 8.905
October 07, 2026 9.134
October 06, 2026 9.039
October 05, 2026 9.118
October 02, 2026 9.112
October 01, 2026 9.090
September 30, 2026 9.110
September 29, 2026 9.12
September 28, 2026 9.199
September 25, 2026 9.021
September 24, 2026 9.225
September 23, 2026 8.922
September 22, 2026 9.500
September 21, 2026 9.501
Date Value
September 18, 2026 9.466
September 17, 2026 9.559
September 16, 2026 9.904
September 15, 2026 9.588
September 14, 2026 10.59
September 11, 2026 10.54
September 10, 2026 10.45
September 09, 2026 10.43
September 08, 2026 10.80
September 04, 2026 10.82
September 03, 2026 10.84
September 02, 2026 10.69
September 01, 2026 10.41
August 31, 2026 10.52
August 28, 2026 9.913
August 27, 2026 9.971
August 26, 2026 10.01
August 25, 2026 10.12
August 24, 2026 10.07
August 21, 2026 10.13
August 20, 2026 10.19
August 19, 2026 10.38
August 18, 2026 9.951
August 17, 2026 9.893
August 14, 2026 9.937

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. 1.713
Novo Nordisk A/S 5.101
Evaxion AS 3.290
Genmab A/S 4.389
Zealand Pharma A/S 0.8591

Price to Book Value Related Metrics